Literature DB >> 15778490

Asthma: one hundred years of treatment and onward.

Eric K Chu1, Jeffrey M Drazen.   

Abstract

There have been four types of drug treatment of asthma that have been used over the past 100 years. Belladonna alkaloids, derived from the thorn-apple plant were used in 1905, and chemically synthesized entities in this class are still in use today. Western medicine began to use adrenergic stimulants approximately 100 years ago, but they were likely used in Asian medicine long before that. Systemic treatment with corticosteroids was introduced into the treatment of asthma in the mid-20th century; inhaled corticosteroids have been in use for over 35 years. The last 40 years have also seen the development of the first targeted asthma treatments: cromones, antileukotrienes, and anti-IgE. As we learn more of the biology of asthma, we anticipate that more effective targeted asthma treatments will be developed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778490     DOI: 10.1164/rccm.200502-257OE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  23 in total

Review 1.  Pharmacotherapy of asthma.

Authors:  Martin M Zdanowicz
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

2.  MicroRNA Targets for Asthma Therapy.

Authors:  Sabrina C Ramelli; William T Gerthoffer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  β2 Agonists.

Authors:  Charlotte K Billington; Raymond B Penn; Ian P Hall
Journal:  Handb Exp Pharmacol       Date:  2017

4.  Dehydroepiandrosterone suppresses eosinophil infiltration and airway hyperresponsiveness via modulation of chemokines and Th2 cytokines in ovalbumin-sensitized mice.

Authors:  Chian-Jiun Liou; Wen-Chung Huang
Journal:  J Clin Immunol       Date:  2011-06-04       Impact factor: 8.317

Review 5.  Inflammatory Basis of Pulmonary Arterial Hypertension: Implications for Perioperative and Critical Care Medicine.

Authors:  Neil M Goldenberg; Marlene Rabinovitch; Benjamin E Steinberg
Journal:  Anesthesiology       Date:  2019-10       Impact factor: 7.892

Review 6.  Evolving Concepts of Asthma.

Authors:  Marc Gauthier; Anuradha Ray; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

Review 7.  Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.

Authors:  Caleb F Anderson; Maria E Grimmett; Christopher J Domalewski; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-10

8.  Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.

Authors:  George Gallos; Gene T Yocum; Matthew E Siviski; Peter D Yim; Xiao Wen Fu; Michael M Poe; James M Cook; Neil Harrison; Jose Perez-Zoghbi; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-06       Impact factor: 5.464

9.  Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture.

Authors:  Lei-Miao Yin; Gong-Hao Jiang; Yu Wang; Yan Wang; Yan-Yan Liu; Wei-Rong Jin; Yu-Dong Xu; Qing-Hua Zhang; Yong-Qing Yang
Journal:  J Biomed Sci       Date:  2009-05-06       Impact factor: 8.410

10.  Targeting the γ-Aminobutyric Acid A Receptor α4 Subunit in Airway Smooth Muscle to Alleviate Bronchoconstriction.

Authors:  Gene T Yocum; George Gallos; Yi Zhang; Rajwana Jahan; Michael Rajesh Stephen; Zdravko Varagic; Roshan Puthenkalam; Margot Ernst; James M Cook; Charles W Emala
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.